fda semaglutide compound Novo Nordisk asks to block compounding pharmacies from making Ozempic copycats Compounded GLP-1s: Why doctors worry

Tirzepatide for managing overweight and obesity - technology appraisal guidance TA1026 nice.org.uk Overweight and obesity in adults, NHS nhs.uk NHS England

Semaglutide is typically administered as a subcutaneous injection, meaning its injected under the skin

This isnt something you should be doing on your own, though

and Onyango B

15 Scenario: A patent covers the method of using a drug for weight loss, but the drug itself (the molecule) is off-patent or available

Individuals interested in exploring growth hormone secretagogue therapy should consult with a licensed healthcare provider to discuss whether such therapy is appropriate for their individual circumstances